BR9811478A - Polymer-tannic acid compositions for the controlled release of pharmaceutical agents particularly in the oral cavity - Google Patents

Polymer-tannic acid compositions for the controlled release of pharmaceutical agents particularly in the oral cavity

Info

Publication number
BR9811478A
BR9811478A BR9811478-6A BR9811478A BR9811478A BR 9811478 A BR9811478 A BR 9811478A BR 9811478 A BR9811478 A BR 9811478A BR 9811478 A BR9811478 A BR 9811478A
Authority
BR
Brazil
Prior art keywords
pharmaceutical agents
oral cavity
tannic acid
controlled release
polymer
Prior art date
Application number
BR9811478-6A
Other languages
Portuguese (pt)
Inventor
E Itzhak Lerner
Vered Rosenberger
Moshe Flashner
Original Assignee
Perio Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perio Prod Ltd filed Critical Perio Prod Ltd
Publication of BR9811478A publication Critical patent/BR9811478A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Abstract

"COMPOSIçõES DE POLìMERO-áCIDO TâNICO PARA A LIBERAçãO CONTROLADA DE AGENTES FARMACêUTICOS PARTICULARMENTE NA CAVIDADE ORAL" A presente invenção está orientada para composições de liberação controlada ou sustentada de agentes farmacêuticos ou outros. Os componentes essenciais nas composições da presente invenção incluem um ou mais polímeros e ácido tânico ou tanino. A liberação de agentes farmacêuticos ou outros agentes é por um período de tempo predeterminado e a uma concentração predeterminada. O campo de ação do agente é tópico, local ou sistêmico. Os polímeros são celulósicos ou proteináceos."TONIC POLYMERIC ACID COMPOSITIONS FOR THE CONTROLLED RELEASE OF PHARMACEUTICAL AGENTS PARTICULARLY IN THE ORAL CAVITY" The present invention is directed to controlled or sustained release compositions of pharmaceutical or other agents. The essential components in the compositions of the present invention include one or more polymers and tannic acid or tannin. The release of pharmaceutical agents or other agents is for a predetermined period of time and at a predetermined concentration. The agent's field of action is topical, local or systemic. Polymers are cellulosic or proteinaceous.

BR9811478-6A 1997-07-23 1998-07-22 Polymer-tannic acid compositions for the controlled release of pharmaceutical agents particularly in the oral cavity BR9811478A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89912197A 1997-07-23 1997-07-23
PCT/US1998/015096 WO1999004764A1 (en) 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Publications (1)

Publication Number Publication Date
BR9811478A true BR9811478A (en) 2000-08-15

Family

ID=25410514

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811478-6A BR9811478A (en) 1997-07-23 1998-07-22 Polymer-tannic acid compositions for the controlled release of pharmaceutical agents particularly in the oral cavity

Country Status (10)

Country Link
EP (1) EP1003483A1 (en)
JP (1) JP2001510788A (en)
KR (1) KR20010021911A (en)
AU (1) AU8578498A (en)
BR (1) BR9811478A (en)
CA (1) CA2296654A1 (en)
HU (1) HUP0002490A2 (en)
IL (1) IL134151A0 (en)
NO (1) NO20000284L (en)
WO (1) WO1999004764A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
EP1305021A4 (en) * 2000-06-23 2009-09-23 Teva Pharma Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US6881420B2 (en) 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
ES2288823T3 (en) * 2000-09-01 2008-02-01 Cognis Ip Management Gmbh AGENT FOR ORAL AND DENTAL CARE.
JP4820024B2 (en) 2001-01-10 2011-11-24 昭和薬品化工株式会社 Local anesthetic composition
JP5089840B2 (en) * 2001-09-25 2012-12-05 救急薬品工業株式会社 Nicotine-containing film preparation
EP1446167A4 (en) * 2001-11-05 2010-09-29 Orahealth Corp Treating canker sores with patches to speed healing and relieve pain
CA2518329C (en) 2003-03-12 2015-11-24 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
US20040185009A1 (en) * 2003-03-19 2004-09-23 Dexcel Pharma Technologies Ltd. Composition and device for treating periodontal diseases
JP4931596B2 (en) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー Tobacco composition
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2005048965A2 (en) * 2003-11-13 2005-06-02 Wm. Wrigley Jr. Company Method and composition for breath freshening
ES2400687T3 (en) * 2004-04-23 2013-04-11 Amgen Inc. Sustained Release Formulations
CA2649149A1 (en) * 2006-04-11 2007-10-25 Koko Kosmetikvertrieb Gmbh & Co. Kg Nanoparticle containing nicotine and/or cotinine, dispersions, and use thereof
US8642088B2 (en) 2009-09-04 2014-02-04 Wisconsin Alumni Research Foundation Tannin-chitosan composites
KR101307367B1 (en) 2010-09-14 2013-09-25 주식회사 이노테라피 Adhesive composition comprising tannin, polyethylene glycol, and water, low carbon alcohol or the mixture thereof
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
FR2972327B1 (en) * 2011-03-11 2017-08-11 Laboratoires Le Stum MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20130158132A1 (en) * 2011-12-19 2013-06-20 Aida Salatinjants Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
WO2015167257A1 (en) * 2014-04-29 2015-11-05 포항공과대학교 산학협력단 Composition for oral application and method for preparing same
RU2606589C2 (en) * 2015-02-16 2017-01-10 Александр Александрович Кролевец Method of producing tannin nanocapsules
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
CA3146610A1 (en) * 2019-08-16 2021-02-25 Adel Penhasi Adhesive drug delivery microparticles and a product comprising thereof
CN115477920A (en) * 2021-06-15 2022-12-16 西南大学 Preparation method of tannin-based underwater adhesive and product
KR20230146888A (en) 2022-04-13 2023-10-20 경북대학교 산학협력단 Drug sustained-release self-healing coating layer for dental restoration and manufacturing method thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB104609A (en) * 1916-06-05 1917-03-15 Monneron & Guye A Method of Manufacturing a Medicinal Aluminium Preparation.
GB918754A (en) * 1959-08-14 1963-02-20 Armour & Co Improvements in or relating to corticotrophin preparations
GB2036750B (en) * 1978-11-23 1983-05-05 Payne M Tannin complexes
JPS5846011A (en) * 1981-09-14 1983-03-17 Kao Corp Hair treatment
JPH01166763A (en) * 1987-12-22 1989-06-30 Nitta Gelatin Inc Medical and dental curable material
AU2252388A (en) * 1988-05-02 1989-11-29 Zila Pharmaceuticals Compositions and in situ methods for forming films on body tissue
JPH04114655A (en) * 1990-09-03 1992-04-15 Shinonaga Kasei Kk Hard composition for medical use
JPH04312522A (en) * 1991-04-08 1992-11-04 Yoshiaki Kawashima Production of sustained release tablet
JP3496727B2 (en) * 1993-12-27 2004-02-16 救急薬品工業株式会社 Pharmaceutical base
JPH08319232A (en) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd Particulate composition
JP2885668B2 (en) * 1995-09-29 1999-04-26 沢井製薬株式会社 Teprenone formulation

Also Published As

Publication number Publication date
IL134151A0 (en) 2001-04-30
HUP0002490A2 (en) 2000-12-28
AU8578498A (en) 1999-02-16
WO1999004764A1 (en) 1999-02-04
NO20000284D0 (en) 2000-01-20
KR20010021911A (en) 2001-03-15
EP1003483A1 (en) 2000-05-31
JP2001510788A (en) 2001-08-07
CA2296654A1 (en) 1999-02-04
NO20000284L (en) 2000-03-22

Similar Documents

Publication Publication Date Title
BR9811478A (en) Polymer-tannic acid compositions for the controlled release of pharmaceutical agents particularly in the oral cavity
BR9807383A (en) Pharmaceutical formulation comprising amoxicillin and clavulanate
BR0113663A (en) Pectin Film Compositions
KR930016091A (en) Method for preparing a solid dispersion of an almost water-insoluble drug
BRPI9908182B8 (en) wound healing matrix protein compositions
BR9812018A (en) Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
BR0316310A (en) Pharmaceutical compositions having a modified vehicle
BR9909565A (en) Bicyclic derivatives of hydroxamic acid
ES2190075T3 (en) SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULFOALQUIL-ETER-CYCLODEXTRINE AND A THERAPEUTIC AGENT.
BR9713866A (en) Pharmaceutical composition
BR9806236A (en) Use of at least one aminophenol derivative, cosmetic and / or dermatological composition, aminophenol derivatives and cosmetic depigmenlos or hair process
FR2628319B1 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON BENZOYL PEROXIDE AND QUATERNARY AMMONIUM SALTS
BR0112142A (en) Skin care composition and cosmetic methods of conditioning skin and reproducing the effect on skin of retinoic acid
FR2779648B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID AND MAY BE DEFORMABLE
BR9801652A (en) Resorcinyl-triazines
BR9914514A (en) Improved paper sizing agents and papermaking and agent manufacturing processes
BR9805231A (en) Cosmetic and / or dermatological composition, cosmetic use of the composition and cosmetic process of cleaning and / or skin treatment.
BR9913589A (en) Composition, and, cosmetic process to reduce burning or irritation induced by topical application of a composition
BR0007294A (en) Improved pharmaceutical formulations
BR0015416A (en) Compositions containing tetraenoic hydroxyieic acid derivatives and methods of use in the treatment of dry eye disorders
BR9913135A (en) Oral formulation
ES2168457T3 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A DISMUTE SUPEROXIDE.
BR9904613A (en) Use of a silicone gum, topical composition and use of a composition
BR9809571A (en) Medicinal composition and process to produce it
DE69806962T2 (en) FSNMU as an anti-inflammatory agent in the surface tissues of mammals

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]